Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the blood cells. The term “chronic” in chronic myelogenous leukemia indicates that this cancer tends to progress more slowly than acute forms of leukemia. The term “myelogenous” (my-uh-LOHJ-uh-nus) in chronic myelogenous leukemia refers to the type of cells affected by this cancer. Chronic myelogenous leukemia can also be called chronic myeloid leukemia and chronic granulocytic leukemia. Chronic myelogenous leukemia typically affects older adults and rarely occurs in children, though it can occur at any age. Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It’s a type of cancer that starts in certain blood-forming cells of the bone marrow. In CML, a genetic change takes place in an early (immature) version of myeloid cells — the cells that make red blood cells, platelets, and most types of white blood cells (except lymphocytes).
For More: http://www.sciaeon.org/cancer-biology-and-clinical-oncology/home
Manuscript Submission: http://www.sciaeon.org/submit-paper
Contact: cancerbiology@sciaeonopenaccess.com
Journal of Cancer Biology and Clinical Oncology 